Home Law \ Legal Latham & Watkins Advises Boston Scientific Corporation in its Acquisition of Obsidio, Inc.

Latham & Watkins Advises Boston Scientific Corporation in its Acquisition of Obsidio, Inc.

1 min read
Comments Off on Latham & Watkins Advises Boston Scientific Corporation in its Acquisition of Obsidio, Inc.
0
32


Boston Scientific Corporation (NYSE: BSX) has announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEM™) technology used for embolization of blood vessels in the peripheral vasculature.

Latham & Watkins LLP represents Boston Scientific Corporation in the transaction with a corporate deal team led by Boston partner Julie Scallen, with Boston associates Stefanie Vincent, Michael Casagrande, Andrew Rondeau, and Nicole Angelica. Advice was also provided on tax matters by Washington, D.C. partner Nicholas DeNovio, with Washington, D.C. associates Pierce Pandolph and Emmanuel Kassim; on benefits and employment matters by Chicago partner Benjamin Rosemergy, with Chicago associate Daniel Gocek; and on healthcare regulatory matters by Washington, D.C. partner Elizabeth Richards and Bay Area counsel Betty Pang.





Source link

Load More Related Articles
Load More By James Tisdale
Load More In Law \ Legal
Comments are closed.

Check Also

Super League 25th Grand Final

Last Updated on 25 Sep 2022 7:14 pm (UK Time) Old Trafford hosted a crowd of 60,783 to wit…